A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Jun 2015
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms ACTS-RC
- 22 Jun 2015 Planned End Date changed from 1 Mar 2014 to 1 Apr 2014 as reported by the University Hospital Medical Information Network - Japan record.
- 29 May 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 29 May 2015 Primary endpoint has been met (relapse-free survival) according to results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.